Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Nov 8 - Nov 13
Bulking phase (muscle building): Lower doses (0.5 to 2 mg/week) for appetite control without excessive satiety
The STEP trials showed that adults taking semaglutide lost 9.2% to 17.4% of their body weight over 68 weeks, compared to 2.4% with placebo
One study demonstrated that exendin-4 (50 nM) treatment reduces the expression of pro-inflammatory genes such as NF-B p65 and the TNF receptor superfamily member 1A in human pancreatic islet cells (Velmurugan et al., 2012)
Key Takeaways Retatrutide is a once-weekly injectable triple agonist targeting GLP-1, GIP, and glucagon receptors Starting dose is typically 1 mg weekly, titrating up gradually to minimize side effects Maintenance doses range from 8 mg to 12 mg weekly based on individual response Titration is critical for balancing weight loss efficacy with tolerability Clinical trials show significant weight reduction compared to placebo Always work with a healthcare provider to determine your optimal dosing schedule Overview of Retatrutide What is Retatrutide
Instead, these patches are a combination of different vitamins and compounds that may support weight loss, making them cheaper than prescription weight loss drugs
doi: 10.1016/j.cmet.2011.03.004
